captopril has been researched along with Kidney Diseases in 148 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 52 (35.14) | 18.7374 |
1990's | 48 (32.43) | 18.2507 |
2000's | 29 (19.59) | 29.6817 |
2010's | 16 (10.81) | 24.3611 |
2020's | 3 (2.03) | 2.80 |
Authors | Studies |
---|---|
Jaiswal, A; Semwal, BC; Singh, S | 1 |
Gao, W; Liu, C; Lu, G; Man, S; Wang, Y; Xiang, H; Yang, L | 1 |
Abeyat, H; Behmanesh, MA; Poormoosavi, SM; Sangtarash, E | 1 |
Beheshti, F; Bideskan, AE; Hosseinian, S; Mohebbati, R; Motejadded, F; Rad, AK; Sadeghnia, H; Shafei, MN; Shahraki, S; Soukhtanloo, M | 1 |
Alimoradian, A; Changizi-Ashtiyani, S; Ghiasabadi Farahani, A; Kheder, L; Rajabi, R; Sharifi, A | 1 |
Chowdhury, MS; Eva, EO; Saha, SK; Sarker, MM | 1 |
Aronow, B; Cancelas, JA; Chang, KH; Eiymo Mwa Mpollo, MS; Inagami, T; Malik, P; Rai, P; Rizvi, T; Roy, S; Shanmukhappa, SK; VandenHeuvel, K | 1 |
Ebrahimzadeh Bideskan, A; Hosseinian, S; Khajavi Rad, A; Sadeghnia, HR; Samadi Noshahr, Z; Shafei, MN; Shahraki, S; Soukhtanloo, M | 1 |
Borghi, C; Omboni, S | 1 |
Bush, ED; Fabian, E; Herold, M; Kamp, HG; Krennrich, G; Looser, R; Mattes, WB; Mellert, W; Moeller, N; Nadanaciva, S; Naraoka, H; Omura, K; Piccoli, SP; Prokoudine, A; Ruiz-Noppinger, P; Schuppe-Koistinen, I; Strauss, V; van Ravenzwaay, B; Walk, T | 1 |
Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL | 1 |
Denfield, SD; Dinh, K; Knudson, JD; Kyle, WB; Lindle, KA; Moffett, BS; Montgomery, NM | 1 |
Dursun, N; Kunduz Kindap, E; Ozdogan, K; Taskin, E | 1 |
Cohen, EP; Fish, BL; Moulder, JE | 4 |
Chan, GC; Huang, XR; Lan, HY; Lin, M; Tang, SC; Wong, DW; Wu, HJ; Yiu, WH | 1 |
Chan, GCW; Chan, KW; Huang, XR; Lai, KN; Lan, HY; Tang, SCW; Wu, HJ; Yiu, WH; Zou, A | 1 |
Fisher, ND; Patel, TV; Williams, GH | 1 |
Baenziger, O; Bauersfeld, U; Bernet, V; Frey, B; Gantenbein, MH; Neuhaus, T; Sennhauser, F | 1 |
Abd-Ellah, MF; Attia, SM; El-Sayed, el-SM | 1 |
Blantz, RC; Deng, A; Satriano, J; Singh, P; Tang, T; Thomson, SC; Wang, C | 1 |
Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z; Naumovic, R | 1 |
Gao, J; Li, Q; Liu, BC; Xu, LM | 1 |
de Zeeuw, D; Lambers-Heerspink, H | 1 |
Kato, H; Murakami, M; Murakami, T; Ninomiya, T; Osajima, K; Otani, L | 1 |
Malacco, E; Omboni, S; Parati, G | 1 |
Adams, L; Baron, AD; Broyde, A; Fernandez, R; Liu, Q; Parkes, DG | 1 |
Burnier, M; Martin, PY | 1 |
Al-Mulhim, AS; Fouad, AA; Jresat, I; Morsy, MA | 1 |
Bernich, P; Marcantoni, C; Maschio, G | 1 |
Eguchi, K; Kario, K; Shimada, K | 1 |
Hasegawa, T; Ideura, T; Inui, K; Minamoto, T; Morita, H; Nakamoto, Y; Nakao, N; Oda, Y; Tayama, H; Yoshimura, A | 1 |
Chow, L; Kwan, TH; Mok, CC | 1 |
Kupfer, Y; Moshenyat, R; Tessler, S | 1 |
Anavekar, NS; Califf, RM; Dickstein, K; Kober, L; Leimberger, JD; Maggioni, A; McMurray, JJ; Nordlander, R; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, EJ; White, HD; Zelenkofske, S | 1 |
Braunwald, E; Chertow, GM; Kenchaiah, S; Moyé, LA; Packer, M; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Tokmakova, MP | 1 |
Aoki, M; Inagaki, O; Uchida, W; Yatsu, T | 1 |
de Zeeuw, D; Henning, RH; Kluppel, CA; Kok, RJ; Moolenaar, F; Prakash, J; van Dokkum, RP; Windt, WA | 1 |
Tan, J; Wei, L | 1 |
Anavekar, NS; Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, E; White, H | 1 |
Danielson, BG; Lindsjö, M; Weiss, L; Wikström, B | 1 |
Kulaga, SF; McFate Smith, W; Moncloa, F; Pingeon, R; Walker, JF | 1 |
Donker, AJ; Hoedemaeker, PJ; Hoorntje, SJ; Kallenberg, CG; The, TH; Weening, JJ | 1 |
Porush, JG | 1 |
Limone, P; Molinatti, GM | 1 |
Harrell, RM; Sibley, R; Vogelzang, NJ | 1 |
Brunner, HR; Gavras, H; Guignard, JP; Turini, GA; Waeber, B; Wauters, JP | 1 |
Campbell, BC; Elliott, HL; McLean, K; Reid, JL; Shepherd, AN | 1 |
Kincaid-Smith, P; Murphy, BF; Whitworth, JA | 1 |
Hymes, LC; Warshaw, BL | 1 |
Brown, EA; Macgregor, GA; Maini, RN | 1 |
Drayer, JI; Weber, MA | 1 |
Green, TP; Hendrick, DA; Mirkin, BL; O'Dea, RF; Sinaiko, AR | 1 |
Alexander, JC; Thurm, RH | 1 |
Antonovych, TT | 1 |
Maher, JF | 1 |
Dumler, F | 1 |
Guignard, JP | 1 |
Gärtner, HV | 1 |
Fujimi, S; Hirakata, H; Iseki, K; Kawahara, Y; Omae, T; Onoyama, K | 1 |
Battilana, G; Bellini, G; Carraro, M; Carretta, R; Englaro, E; Fabris, B; Faccini, L; Menchini, U; Puppis, E; Rigoni, A; Rustia, R | 1 |
McDougal, WS | 1 |
Cruickshank, HE | 1 |
Geraci, JP; Mariano, MS; Sun, MC | 1 |
Fommei, E; Volterrani, D | 1 |
Moser, E | 1 |
Banisadr, F; Buzelin, F; Grolleau, JY; Hamidou, MA; Jego, P; Moreau, A; Testa, A | 1 |
Campese, VM; Huang, TP; Liou, HH | 1 |
Aono, H; Ikuse, T; Okahara, A; Takase, K | 1 |
Fluck, RJ; Raine, AE | 1 |
Cooke, HM; De Besse, A | 1 |
Cohen, EP; Fish, BL; Hill, P; Moulder, JE | 1 |
Zuccalà, A; Zucchelli, P | 1 |
Ali, BH; Bashir, AA | 2 |
Brambs, HJ; Duda, SH; Gregor, M; Huppert, PE; Raible, RT; Risler, T | 1 |
Cerasola, G; Contorno, A; Cottone, S; Giuntini, G; Mangano, MT; Mercadante, G; Rabiolo, A | 1 |
Averbuch, M; Dotan, I; Golan, Y; Iaina, A; Kornowski, R; Levo, Y; Schwartz, D; Schwartz, IF; Weinreb, B | 1 |
Critchley, M | 1 |
Carone, FA; Cohen, EP; Fish, BL; Hill, P; Molteni, A; Moulder, JE; Ward, WF | 1 |
Dondi, M; Fanti, S; Monetti, N | 1 |
Abe, K; Kanazawa, M; Kohzuki, M; Liu, PF; Obara, K; Saito, T; Sato, T; Yasujima, M; Yoshida, K | 1 |
Bogdanović, G; Djukanović, Lj; Dragojlović, Z; Funduk, G; Jovanović, D; Jovanović, Z; Starcević-Bozović, Z; Susić, D | 1 |
Bondía, A; Corbacho, L; Deira, JL; García, P; Gascón, A; Lerma, JL; Martín, B; Tabernero, JM | 1 |
Naitoh, T; Shikada, K; Tanaka, S; Yotsumoto, T | 1 |
Grassia, C; Lama, G; Pedulla', M; Ruocco, G; Salsano, ME | 1 |
Krakoff, LR; Rajasekharaiah, V | 1 |
Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Starcevic, A; Varagic, J | 1 |
Aktan, AO; Bilsel, S; Moini, H; Sarac, AM; Scapa, E | 1 |
Al-Shabanah, OA; El-Kashef, HA; Mansour, MA | 1 |
Przedlacki, J; Smoszna, J; Stembrowicz, Z; Wańkowicz, Z | 1 |
Linshaw, MA; Milner, LS; Sadeghi-Nejad, A; Yuskiw, M | 1 |
Chan, JC; Fan, WC; Lo, SS; Wong, KW; Yung, BC | 1 |
Cruz, CI; del Moral, RG; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Torres, P | 1 |
Bianchetti, MG; Meregalli, P; Mozzettini, S; Ramelli, GP; Truttmann, AC; von Vigier, RO | 1 |
Babic, D; Nastic-Miric, D; Peco-Antic, A; Pejcic, I | 1 |
Cohen, EP; Fish, BL; Moulder, JE; Regner, K | 1 |
Atarashi, K; Ishiyama, A; Minami, M; Takagi, M | 1 |
Coca, A; Ruilope, LM | 1 |
Walls, J | 1 |
Dokucu, AI; Gezici, A; Ketani, A; Otçu, S; Ozdemir, E; Oztürk, H; Yildiz, FR; Yücesan, S | 1 |
Cohen, EP; Fish, BL; Molteni, A; Moulder, JE; Taylor, JM; Veno, PA; Ward, WF; Wolfe, LF | 1 |
Studney, D | 1 |
Donker, AJ; Hoorntje, SJ; Kallenberg, CG; Prins, EJ; Weening, JJ | 1 |
Anikina, NV; Guseva, NG; Shcherbakov, AB | 1 |
Andrés, A; Hernández, E; Montoyo, C; Praga, M; Rodicio, JL; Ruilope, LM | 1 |
Balfe, JW; Ellis, G; Hamed, RM; Levy, M; McLorie, GA | 1 |
Zawada, ET | 1 |
Basinger, MA; Holscher, MA; Jones, MM | 1 |
Balfe, JW; Klein, J; Koren, G; Levy, M; McLorie, G | 1 |
Balfe, JW; Ellis, G; Hamed, RM | 1 |
de Jong, PE; de Zeeuw, D | 1 |
Collier, BD; Lemann, J; Lipchik, EO; Taylor, AJ | 1 |
Groniowski, M; Hasse, Z; Lewandowski, Z; Ludwicka, A; Niemczyk, S; Stopiński, M | 1 |
Carson, P; Odum, J; Russell, G | 1 |
Mulcahy, WS; Price, BA; Rodel, PV; Smith, RD | 1 |
Bantle, JP; Boudreau, RJ; Ferris, TF; Olivari, MT; Paller, MS | 1 |
Bakri, F; Bosquet, D; Droy, MT; Guillemain, J; Lhuintre, Y; Ruchoux, MM | 1 |
Giménez García, RM; Gómez-Martino Arroyo, JR; Mateos Polo, L; Rodríguez Prieto, MA | 1 |
Fettman, MJ; Hamar, DW; Mikita, DJ; VanHouten, DS; Wilke, WL | 1 |
Dreslinski, GR; Fand, R; Groel, JT; Herczeg, SA; Jenkins, AC; Tadros, SS | 1 |
Fettman, MJ; Radin, MJ; Wilke, WL | 1 |
Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
Gauthier, B; Trachtman, H | 1 |
Murchison, LE; Robb, OJ; Webster, J | 1 |
Edwards, CR; Padfield, PL | 1 |
Hillis, WS; Hogg, KJ | 1 |
Materson, BJ | 1 |
Pitt, B | 1 |
Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
Hill, GS | 1 |
Cobden, I; Record, CO; Shore, A; Wilkinson, R | 1 |
Davies, RO; Irvin, JD; Kramsch, DK; Moncloa, F; Walker, JF | 1 |
Thind, GS | 1 |
Irvin, JD; Viau, JM | 1 |
Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
Lewis, EJ | 1 |
Donker, AJ | 1 |
Kawashima, K; Saito, K; Sokabe, H; Watanabe, TX | 1 |
Adler, SG; Border, WA; Cohen, AH | 1 |
Berg, KJ; Fauchald, P; Hartmann, A; Holdaas, H; Nordal, KP; Talseth, T | 1 |
Kashiwazaki, S; Okada, J; Suzuki, T | 1 |
Radó, J | 1 |
Arbeit, LA; Devarajan, P; Kaskel, FJ; Moore, LC; Partin, JS | 1 |
Beckett, VL; Brennan, LA; Chao, EY; Conn, DL; Donadio, JV; Holley, KE; Osmundson, PJ | 1 |
Hansen, BL; Henriksen, IO; Kemp, E | 1 |
21 review(s) available for captopril and Kidney Diseases
Article | Year |
---|---|
Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Kidney Diseases; Treatment Outcome | 2019 |
Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Metabolic Diseases | 2009 |
Lessons from large interventional trials on antihypertensive therapy in chronic renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Chronic Disease; Clinical Trials as Topic; Humans; Kidney Diseases; Kidney Failure, Chronic; Nifedipine; Treatment Outcome | 2002 |
[What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Captopril; Cardiomegaly; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetic Retinopathy; Humans; Hypertension; Irbesartan; Kidney Diseases; Losartan; Practice Guidelines as Topic; Risk; Tetrazoles | 2002 |
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
Topics: Acromegaly; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Cushing Syndrome; Glycoproteins; Humans; Hyperaldosteronism; Hypertension; Kidney; Kidney Diseases; Prostaglandins; Receptors, Adrenergic; Receptors, Angiotensin; Renin; Sodium; Sympathetic Nervous System; Teprotide | 1981 |
Drug-induced nephropathies.
Topics: Allopurinol; Aminoglycosides; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Captopril; Cephalosporins; Cisplatin; Diuretics; Glomerulonephritis; Gold; Humans; Kidney; Kidney Diseases; Kidney Tubular Necrosis, Acute; Lithium; Nephritis, Interstitial; Penicillamine; Penicillins; Rifampin; Semustine; Sulfonamides; Tetracycline; Trimethadione | 1984 |
Clinicopathologic spectrum of drug nephrotoxicity.
Topics: Aminoglycosides; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Captopril; Cimetidine; Contrast Media; Cyclosporins; Drug-Related Side Effects and Adverse Reactions; Glomerulonephritis; Gold; Humans; Ischemia; Kidney; Kidney Diseases; Kidney Diseases, Cystic; Kidney Papillary Necrosis; Kidney Tubular Necrosis, Acute; Lithium; Nephrotic Syndrome; Toxins, Biological | 1984 |
Renal nuclear medicine.
Topics: Captopril; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Radioisotope Renography; Urinary Tract Infections | 1995 |
ACE inhibitors in non-diabetic renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension, Renal; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Renin-Angiotensin System | 1994 |
Pharmacological treatment of renal parenchymal hypertension.
Topics: Antihypertensive Agents; Captopril; Humans; Hypertension, Renal; Incidence; Kidney Diseases; Models, Biological; Multicenter Studies as Topic; Nifedipine; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies | 1994 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors | 2000 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
[Renal effects of angiotensin-converting enzyme inhibitors: from the feared side effect to the desired treatment goal].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Kidney; Kidney Diseases; Radioisotope Renography | 1991 |
Long-term renal effects of enalapril therapy in patients with renal insufficiency.
Topics: Aged; Blood Pressure; Captopril; Enalapril; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Proteinuria; Time Factors | 1990 |
Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Eruptions; Drug Interactions; Enalapril; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Neutropenia; Proline; Taste Disorders | 1985 |
Special uses for captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Edema; Humans; Hypertension; Kidney Diseases; Renal Artery Obstruction; Renin-Angiotensin System; Scleroderma, Systemic; Takayasu Arteritis | 1987 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
Glomerular abnormalities in patients receiving angiotensin converting enzyme inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Glomerulonephritis; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus | 1987 |
Nephrotoxicity of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension, Renal; Kidney Diseases; Nephritis, Interstitial; Renal Artery Obstruction | 1987 |
Hypersensitivity phenomena and the kidney: role of drugs and environmental agents.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antibodies; Captopril; Drug Hypersensitivity; Environmental Exposure; Glomerulonephritis; Gold; Heroin; Humans; Hydrocarbons; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mercury; Nephritis, Interstitial; Penicillamine; Penicillins; Rifampin | 1985 |
15 trial(s) available for captopril and Kidney Diseases
Article | Year |
---|---|
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Chronic Disease; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survival Rate; Tetrazoles; Valine; Valsartan | 2004 |
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Risk | 2004 |
Clinical observation on Breviscapine in treating hypertension patients complicated with micro-albuminuria of renal impairment.
Topics: Adult; Aged; Albuminuria; Amlodipine; Antihypertensive Agents; beta 2-Microglobulin; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Flavonoids; Flushing; Humans; Hypertension; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Proteinuria | 2005 |
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Diabetes Complications; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Overall tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Global Health; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Leukopenia; Skin Diseases; Taste Disorders | 1984 |
Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
Topics: Adolescent; Adult; Aldosterone; Captopril; Child; Clinical Trials as Topic; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Placebos; Proline; Renal Dialysis; Renin; Sodium | 1981 |
Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.
Topics: Adolescent; Adult; Captopril; Child; Child, Preschool; Graft Rejection; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Kinetics; Proline; Random Allocation; Renal Artery Obstruction; Renin | 1983 |
Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydralazine; Kidney; Kidney Diseases; Male; Prospective Studies; Proteinuria; Renin | 1995 |
Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Creatinine; Drug Interactions; Enalapril; Guidelines as Topic; Humans; Kidney; Kidney Diseases; Prospective Studies | 1994 |
Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Male; Predictive Value of Tests; Prospective Studies; Renin; Safety | 1996 |
Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up.
Topics: Adolescent; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Dimercaptosuccinic Acid; Vesico-Ureteral Reflux | 1997 |
[The use of Capoten in systemic scleroderma].
Topics: Acute Disease; Adolescent; Adult; Captopril; Double-Blind Method; Female; Humans; Kidney Diseases; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic | 1992 |
[Worldwide experience with enalapril].
Topics: Captopril; Clinical Trials as Topic; Drug Eruptions; Enalapril; Gout; Humans; Hypertension; Kidney Diseases; Leukocyte Count | 1985 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
[Captopril in the treatment of hypertension in patients with renal insufficiency].
Topics: Adolescent; Adult; Blood Pressure; Captopril; Child; Clinical Trials as Topic; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged | 1985 |
113 other study(ies) available for captopril and Kidney Diseases
Article | Year |
---|---|
Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephropathy in Rats.
Topics: Animals; Captopril; Endothelin-1; Hyperlipidemias; Kidney Diseases; Rats | 2023 |
Antihypertensive and renal protective effect of Shunaoxin pill combined with captopril on spontaneous hypertension rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Captopril; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelin-1; Gene Expression Regulation; Hypertension; Kidney Diseases; Lipid Metabolism; Nitric Oxide; Nitric Oxide Synthase; Random Allocation; Rats; Rats, Inbred SHR | 2020 |
Evaluation of the Effect of Captopril and Losartan on Tacrolimus-induced Nephrotoxicity in Rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Creatinine; Epithelium; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Male; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Tacrolimus | 2021 |
Thymoquinone ameliorates renal damage in unilateral ureteral obstruction in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzoquinones; Biomarkers; Captopril; Chemokine CCL2; Gene Expression Regulation; Kidney; Kidney Diseases; Losartan; Male; Oxidative Stress; Rats; Rats, Wistar; Sulfhydryl Compounds; Ureteral Obstruction | 2017 |
Protective Effects of Pomegranate Juice on Nephrotoxicity Induced by Captopril and Gentamicin in Rats.
Topics: Animals; Biomarkers; Captopril; Cytoprotection; Disease Models, Animal; Fruit and Vegetable Juices; Gentamicins; Kidney; Kidney Diseases; Lythraceae; Male; Malondialdehyde; Natriuresis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Potassium; Rats, Wistar; Renal Elimination; Time Factors | 2017 |
A study on the Effect of Captopril on Gentamicin Induced Nephrotoxicity in Rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Bangladesh; Captopril; Creatinine; Gentamicins; Kidney; Kidney Diseases; Rats | 2018 |
Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy.
Topics: Adult; Anemia, Sickle Cell; Angiotensin II Type 1 Receptor Blockers; Animals; Captopril; Child; Disease Progression; Humans; Kidney Concentrating Ability; Kidney Diseases; Losartan; Mice; Protective Agents; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction | 2018 |
Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Apoptosis; Captopril; Chemokine CCL2; Creatinine; Fibrosis; Inflammation; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Nigella sativa; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Urea; Ureteral Obstruction | 2018 |
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.
Topics: Animals; Captopril; Cyclosporine; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kidney Diseases; Lisinopril; Male; Metabolome; Metabolomics; Phenytoin; Rats; Rats, Wistar | 2013 |
Renin angiotensin system blockade ameliorates lead nephropathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Gene Expression Regulation; Glomerular Filtration Rate; Kidney Diseases; Lead Poisoning; Losartan; Male; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Transforming Growth Factor beta | 2013 |
Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Enalapril; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Premature; Kidney Diseases; Male; Retrospective Studies | 2014 |
The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity.
Topics: Adenosine Triphosphate; Amides; Angiotensin II; Animals; Captopril; Creatine Kinase; Doxorubicin; Fumarates; Kidney; Kidney Diseases; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Renin-Angiotensin System | 2014 |
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation | 2014 |
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chemokine CCL2; Collagen Type IV; Fibrosis; Immunohistochemistry; Inflammation; Kidney Diseases; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred BALB C; Muscle, Smooth; Oligopeptides; Real-Time Polymerase Chain Reaction; Ureteral Obstruction | 2015 |
N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Indoles; Kidney; Kidney Diseases; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Peptidyl-Dipeptidase A; Prolyl Oligopeptidases; Serine Endopeptidases; Serine Proteinase Inhibitors; Signal Transduction; Thiazolidines; Transforming Growth Factor beta1; Ureteral Obstruction | 2018 |
Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Topics: Adult; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Female; Genotype; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Renal Circulation; Renin-Angiotensin System; Vasoconstrictor Agents | 2008 |
Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Heart Failure; Humans; Hypotension; Infant; Infant, Newborn; Kidney Diseases; Male; Retrospective Studies; Treatment Outcome | 2008 |
Protective effect of captopril against cisplatin-induced nephrotoxicity in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Captopril; Cisplatin; Creatinine; Disease Models, Animal; Endothelin-1; Free Radical Scavengers; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nitric Oxide; Rats; Rats, Wistar | 2008 |
Regulation of oxygen utilization by angiotensin II in chronic kidney disease.
Topics: Angiotensin II; Animals; Captopril; Disease Models, Animal; Kidney Diseases; Losartan; Nitric Oxide Synthase; Oxygen Consumption; Rats; Sodium | 2009 |
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Carbazoles; Carvedilol; Creatinine; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Kidney Failure, Chronic; Propanolamines; Proteinuria; Rats; Rats, Inbred SHR; Time Factors | 2009 |
Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cattle; Cell Line; Culture Media, Conditioned; Gene Expression Regulation; Humans; Kidney Diseases; Kidney Tubules; Microscopy, Electron, Transmission; Peptidyl-Dipeptidase A; Proteinuria; RNA, Messenger; Serum Albumin, Bovine | 2009 |
Drug dosing for renoprotection: maybe it's time for a drug efficacy-safety score?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Humans; Hypertension; Kidney Diseases; Proteinuria; Tetrazoles | 2009 |
Sardine peptide with angiotensin I-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Fishes; Hyperglycemia; Hypertension; Kidney Diseases; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Stroke | 2009 |
The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Captopril; Cardiotonic Agents; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Hyperglycemia; Hypertension, Renal; Hypoglycemic Agents; Insulin Resistance; Kidney Diseases; Male; Peptides; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Venoms | 2010 |
[Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Drug Delivery Systems; Drug Interactions; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System; Risk Assessment | 2012 |
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Caspase 3; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fas Ligand Protein; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Kidney Diseases; Male; Malondialdehyde; Microtubule-Associated Proteins; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Survivin; Tumor Necrosis Factor-alpha | 2013 |
Collagenofibrotic glomerulopathy with a widespread expression of type-V collagen.
Topics: Aged; Captopril; Collagen Type III; Collagen Type V; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Kidney Diseases; Kidney Glomerulus; Losartan; Microscopy, Immunoelectron | 2003 |
Scleroderma renal crisis sine scleroderma during pregnancy.
Topics: Adult; Antihypertensive Agents; Arteries; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney; Kidney Diseases; Labetalol; Pre-Eclampsia; Pregnancy; Scleroderma, Systemic | 2003 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Kidney Diseases; Myocardial Infarction; Tetrazoles; Valine; Valsartan | 2004 |
Comparison between YM099 and captopril in rats with renal mass reduction-induced progressive renal disease.
Topics: Animals; Captopril; Cyclic N-Oxides; Kidney Diseases; Male; Oxadiazoles; Potassium Channels; Proteinuria; Rats; Rats, Sprague-Dawley | 2005 |
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Kidney; Kidney Diseases; Male; Muramidase; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Wistar; Sodium, Dietary | 2004 |
Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Creatinine; Dipeptides; Enalapril; Female; Humans; Hypertension, Malignant; Kidney Diseases; Peptidyl-Dipeptidase A; Proline | 1984 |
Immune-complex glomerulopathy in patients treated with captopril.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoantibodies; Biopsy; Captopril; DNA; Female; Humans; Hypertension; Immune Complex Diseases; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Middle Aged; Nephrotic Syndrome; Proline | 1980 |
Managing hypertension in patients with renal disease.
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Humans; Hypertension; Kidney Diseases | 1984 |
Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatin.
Topics: Adult; Bleomycin; Captopril; Cisplatin; Drug Therapy, Combination; Humans; Hypertension, Renovascular; Kidney; Kidney Diseases; Male; Renal Artery Obstruction; Testicular Neoplasms; Vinblastine | 1982 |
Prolonged converting enzyme inhibition following captopril in patients with renal insuffficiency.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Kidney Diseases; Male; Middle Aged; Proline | 1982 |
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorothiazide; Dipeptides; Diuretics; Enalapril; Female; Furosemide; Humans; Kidney Diseases; Nephrosclerosis; Proline | 1984 |
Captopril. Long-term treatment of hypertension in a preterm infant and in older children.
Topics: Adolescent; Captopril; Child; Humans; Hypertension; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Male; Proline; Time Factors | 1983 |
Failure of captopril to reverse the renal crisis of scleroderma.
Topics: Captopril; Female; Humans; Hypertension; Kidney Diseases; Middle Aged; Proline; Scleroderma, Systemic | 1983 |
Severe hypertension: special problems in the elderly.
Topics: Acute Disease; Administration, Oral; Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Brain Diseases; Captopril; Cardiovascular Diseases; Diuretics; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Middle Aged; Obesity; Patient Compliance | 1983 |
Captopril in the treatment of scleroderma renal crisis.
Topics: Adult; Blood Pressure; Captopril; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Proline; Scleroderma, Systemic | 1984 |
Drug-induced glomerulopathy: a selective review.
Topics: Anti-Inflammatory Agents; Captopril; Child; Gold; Humans; Kidney Diseases; Mitomycin; Mitomycins; Penicillamine; Proteinuria; Semustine | 1983 |
Drugs and the neonatal kidney.
Topics: Asphyxia Neonatorum; Captopril; Gentamicins; Humans; Hypoxia; Indomethacin; Infant, Newborn; Infant, Newborn, Diseases; Kidney; Kidney Diseases; Renin-Angiotensin System; Tolazoline | 1982 |
Drug-associated nephropathy. Part I: Glomerular lesions.
Topics: Captopril; Daunorubicin; Gold; Heroin; Humans; Kidney Diseases; Kidney Glomerulus; Mercury; Microscopy, Electron; Penicillamine; Puromycin; Sulfadiazine; Trimethadione | 1980 |
Captopril (SQ 14225) clearance during hemodialysis treatment.
Topics: Adult; Captopril; Female; Humans; Intestinal Absorption; Kidney Diseases; Male; Proline; Renal Dialysis | 1981 |
[Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug].
Topics: Aged; Captopril; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Proline | 1981 |
Pharmacologic preservation of renal mass and function in obstructive uropathy.
Topics: Animals; Captopril; Indomethacin; Kidney; Kidney Diseases; Male; Organ Size; Proline; Rats; Ureteral Obstruction | 1982 |
Angiotensin converting enzyme inhibitors and the otolaryngologist.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Isoquinolines; Kidney Diseases; Lisinopril; Otolaryngology; Quinapril; Tetrahydroisoquinolines | 1995 |
Amelioration of radiation nephropathy in rats by postirradiation treatment with dexamethasone and/or captopril.
Topics: Animals; Captopril; Dexamethasone; Drug Therapy, Combination; Kidney; Kidney Diseases; Male; Radiation Injuries, Experimental; Rats | 1995 |
[Intervention in nuclear medicine kidney diagnosis].
Topics: Aged; Angiography, Digital Subtraction; Captopril; Female; Furosemide; Humans; Hydronephrosis; Infant; Infant, Newborn; Kidney; Kidney Diseases; Middle Aged; Radioisotope Renography; Renal Artery Obstruction; Technetium; Urologic Diseases | 1995 |
Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Arterioles; Aspirin; Captopril; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases | 1995 |
Toxicity study of the angiotensin converting enzyme inhibitor rentiapril in rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Electrolytes; Female; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Sprague-Dawley; Thiazolidines | 1995 |
Prophylaxis of experimental bone marrow transplant nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Captopril; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enalapril; Kidney; Kidney Diseases; Male; Proteinuria; Radiation Injuries, Experimental; Rats; Time Factors; Uremia; Verapamil; Whole-Body Irradiation | 1994 |
Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat.
Topics: Animals; Body Weight; Calcium, Dietary; Captopril; Diltiazem; Female; Gentamicins; Glutathione; Injections, Intramuscular; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley | 1993 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy, Combination; Embolization, Therapeutic; Furosemide; Humans; Indomethacin; Kidney Diseases; Male; Middle Aged; Nephrectomy; Nephrotic Syndrome; Prognosis; Proteinuria; Renal Artery; Renal Dialysis; Treatment Failure | 1994 |
Serum angiotensin-converting enzyme activity in rats with gentamicin-induced nephrotoxicity.
Topics: Animals; Captopril; Creatinine; Female; Gentamicins; Kidney Diseases; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 1993 |
Screening for congenital renovascular hypoplasia and renal artery stenosis by acute converting enzyme inhibition.
Topics: Administration, Oral; Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diagnosis, Differential; Female; Humans; Hypertension, Renovascular; Kidney; Kidney Diseases; Male; Middle Aged; Radiography; Renal Artery Obstruction; Renin; Renin-Angiotensin System | 1993 |
Commentary: renal nuclear medicine. Report on a joint meeting of the BIR's Nuclear Medicine Sub-Committee in association with the IPEMB Radionuclide Special Interest Group, held at the British Institute of Radiology, London, on 22 February 1996.
Topics: Captopril; Diuretics; Humans; Kidney; Kidney Diseases; Radioisotope Renography | 1996 |
Captopril preserves function and ultrastructure in experimental radiation nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arterioles; Captopril; Coloring Agents; Histocytochemistry; Kidney; Kidney Diseases; Male; Microscopy, Electron; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Renal Circulation | 1996 |
Bartter's syndrome: renal scintigraphic appearance after captopril administration.
Topics: Adult; Angiotensin II; Captopril; Female; Humans; Hypokalemia; Kidney; Kidney Diseases; Radioisotope Renography; Renin; Syndrome | 1996 |
Cardiovascular and renal protective effects of losartan in spontaneously hypertensive rats with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hemodynamics; Hypertension; Imidazoles; Kidney Diseases; Losartan; Male; Nephrectomy; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
[The effect of captopril on the development of adriamycin nephropathy in rats with spontaneous arterial hypertension].
Topics: Animals; Blood Pressure; Captopril; Doxorubicin; Female; Hypertension; Kidney Diseases; Rats; Rats, Inbred SHR | 1996 |
Successful brief captopril treatment in experimental radiation nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow Transplantation; Captopril; Kidney; Kidney Diseases; Kidney Function Tests; Nephritis; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Specific Pathogen-Free Organisms; Survival Rate; Whole-Body Irradiation | 1997 |
Captopril hepatotoxicity in a case of renal crisis due to systemic sclerosis.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury; Female; Humans; Kidney Diseases; Scleroderma, Systemic | 1997 |
Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertrophy; Imidazoles; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred Strains; Pyridines; Receptors, Angiotensin; Streptozocin | 1997 |
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Kidney; Kidney Diseases; Kidney Function Tests; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Survival Rate; Tetrazoles; Time Factors; Treatment Outcome | 1998 |
Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Doxorubicin; Female; Hypertension; Kidney Diseases; Kidney Glomerulus; Rats; Rats, Inbred SHR | 1998 |
Brief pharmacological intervention in experimental radiation nephropathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enzyme Inhibitors; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation Injuries, Experimental; Rats; Whole-Body Irradiation | 1998 |
Role of endothelin in obstructive jaundice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; beta-N-Acetylhexosaminidases; Bilirubin; Bosentan; Captopril; Cholestasis; Creatinine; Endothelin Receptor Antagonists; Endothelin-1; Hyaluronic Acid; Kidney Diseases; Liver; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfonamides | 1999 |
Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Blood Proteins; Calcium; Captopril; Creatinine; Doxorubicin; Female; Free Radical Scavengers; Kidney Diseases; Lipid Peroxides; Male; Potassium; Protective Agents; Rats; Serum Albumin; Sodium; Sulfhydryl Compounds; Urea | 1999 |
[Screening for renovascular hypertension in own material (1986-1998)].
Topics: Angiography; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Retrospective Studies | 1998 |
Captopril reduces the proteinuric effect of human growth hormone in adriamycin nephrosis.
Topics: Animals; Captopril; Cholesterol; Disease Models, Animal; Doxorubicin; Growth Hormone; Kidney Diseases; Male; Proteinuria; Rats; Rats, Sprague-Dawley | 1999 |
Negative captopril renography on patients with renin mediated hypertension due to page kidney and reninoma.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Contrast Media; Diagnosis, Differential; Female; Humans; Hypertension, Renovascular; Kidney Diseases; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Radioisotope Renography; Renin; Technetium Tc 99m Mertiatide; Tomography, X-Ray Computed | 1999 |
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Extracellular Matrix Proteins; Fibrosis; Kidney Cortex; Kidney Diseases; Lisinopril; Male; Rats; Rats, Inbred F344; RNA, Messenger; Taurine; Transforming Growth Factor beta | 2000 |
Cough is common in children prescribed converting enzyme inhibitors.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Cough; Enalapril; Female; Humans; Infant; Kidney Diseases; Male; Perindopril; Time Factors | 2000 |
The captopril test: an aid to identify hypertensive children with renal scarring.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Kidney Diseases; Male; Radionuclide Imaging; Renin; Technetium Tc 99m Dimercaptosuccinic Acid; Vesico-Ureteral Reflux | 2000 |
Stenotic glomerulotubular necks in radiation nephropathy.
Topics: Animals; Captopril; Constriction, Pathologic; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Radiation Injuries, Experimental; Rats; Renal Agents | 2000 |
Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Captopril; Cholesterol, Dietary; Kidney; Kidney Diseases; Lipids; Male; Proteinuria; Rats; Rats, Sprague-Dawley | 1999 |
Relationship between proteinuria and progressive renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diet, Protein-Restricted; Disease Progression; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Proteinuria | 2001 |
The protective effects of captopril and nitric oxide on solitary kidney after chronic partial ureteric obstruction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Kidney Diseases; Nitric Oxide; Rats; Rats, Wistar; Ureteral Obstruction; Vasodilator Agents | 2001 |
Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Fibrosis; Imidazoles; Kidney Diseases; Male; Radiotherapy; Rats; Tetrazoles; Time Factors | 2001 |
Serum-sickness-like syndrome with membranous glomerulopathy in patient on captopril.
Topics: Basement Membrane; Captopril; Humans; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Male; Middle Aged; Proline | 1979 |
Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Follow-Up Studies; Glomerulonephritis; Humans; Kidney Diseases; Kidney Function Tests; Male; Nephrotic Syndrome; Prospective Studies; Proteinuria; Time Factors | 1992 |
Captopril test in children with reflux nephropathy.
Topics: Adolescent; Blood Pressure; Captopril; Child; Child, Preschool; Creatinine; Female; Humans; Hypertension, Renovascular; Kidney Diseases; Male; Renin; Renin-Angiotensin System; Vesico-Ureteral Reflux | 1992 |
Geriatrics nephrology.
Topics: Aged; Aging; Captopril; Digoxin; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases; Lung Diseases, Obstructive; Male | 1992 |
Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds.
Topics: Animals; Biotin; Blood Urea Nitrogen; Captopril; Cefoxitin; Cephalexin; Cisplatin; Creatinine; Drug Interactions; Female; Glomerular Filtration Rate; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred DBA; Organ Size; Penicillin G; Rats; Rats, Inbred Strains; Sulfathiazoles; Sulfur; Thiamine | 1992 |
Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring.
Topics: Administration, Oral; Adolescent; Blood Pressure; Captopril; Child; Child, Preschool; Female; Half-Life; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Renin | 1991 |
Use of the captopril test to assess renin responsiveness in children with hypertension and renal disease.
Topics: Captopril; Child; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Renin; Renin-Angiotensin System | 1991 |
Kidney hematoma due to extracorporeal shock wave lithotripsy causing transient renin mediated hypertension.
Topics: Captopril; Hematoma; Humans; Hypertension, Renal; Kidney Diseases; Lithotripsy; Male; Middle Aged; Regional Blood Flow; Renin; Tomography, X-Ray Computed | 1991 |
[Nephrotoxicity of aminoglycosides. III. Preventive studies with subcutaneous administration of converting enzyme inhibitor, captopril].
Topics: Animals; Captopril; Gentamicins; Injections, Subcutaneous; Kidney Diseases; Male; Rats; Rats, Inbred Strains | 1991 |
Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.
Topics: Aged; Captopril; Contraindications; Enalapril; Female; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged | 1991 |
Long-term effects of cyclosporine on renal function in organ transplant recipients.
Topics: Blood Flow Velocity; Blood Pressure; Captopril; Cyclosporins; Glomerular Filtration Rate; Heart Transplantation; Humans; Kidney; Kidney Diseases; Longitudinal Studies; Pancreas Transplantation; Renin; Transplantation; Vascular Resistance | 1990 |
[Comparison of the effects of cicletanine and captopril on kidney and heart lesions in spontaneously hypertensive rats (SHR-SP)].
Topics: Animals; Captopril; Cardiomyopathies; Diuretics; Hypertension; Kidney Diseases; Male; Pyridines; Rats; Rats, Inbred SHR | 1989 |
[Reversible deterioration of renal function, skin exanthema and eosinophilia, in a female patient with chronic kidney insufficiency, after treatment with captopril].
Topics: Captopril; Drug Eruptions; Exanthema; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Middle Aged | 1989 |
Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Topics: Animals; Blood Cell Count; Blood Pressure; Body Weight; Captopril; Chronic Disease; Creatinine; Drinking; Electrolytes; Enalapril; Kidney Diseases; Male; Nephrectomy; Organ Size; Rats; Rats, Inbred Strains; Urodynamics | 1989 |
Captopril in hypertension; seven years later.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Child; Child, Preschool; Creatinine; Female; Humans; Hypertension; Infant; Kidney Diseases; Male; Middle Aged; Product Surveillance, Postmarketing; Proline; Proteinuria | 1985 |
Dose effect of captopril on renal hemodynamics and proteinuria in conscious, partially nephrectomized rats.
Topics: Animals; Blood Pressure; Captopril; Creatinine; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Hemodynamics; Kidney; Kidney Diseases; Male; Nephrectomy; Proteinuria; Rats; Rats, Inbred Strains; Renal Circulation; Vascular Resistance | 1989 |
Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hyponatremia; Kidney Diseases; Male; Middle Aged; Renin; Risk Factors; Sodium | 1987 |
Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Proteinuria; Time Factors | 1988 |
Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Renal Artery Obstruction | 1988 |
Captopril/metolazone induced renal failure.
Topics: Aged; Blood Pressure; Captopril; Diuresis; Diuretics; Drug Interactions; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Metolazone; Natriuresis | 1986 |
[Therapeutic recommendation in cardiac insufficiency. Initial treatment--after infarct--in kidney disease].
Topics: Captopril; Heart Diseases; Humans; Kidney Diseases; Myocardial Infarction | 1987 |
Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.
Topics: Adult; Aged; Captopril; Creatinine; Drug Eruptions; Dysgeusia; Female; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Male; Middle Aged; Renal Circulation; Renin | 1986 |
Drug-associated glomerulopathies.
Topics: Amyloidosis; Animals; Captopril; Cyclosporins; Disease Models, Animal; Gold; Heroin Dependence; Humans; Hydrocarbons; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mercury; Nephrotic Syndrome; Penicillamine; Puromycin Aminonucleoside; Serum Sickness; Solvents; Tetradecanoylphorbol Acetate | 1986 |
Captopril in the hepatorenal syndrome.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Female; Humans; Iodine Radioisotopes; Kidney Diseases; Liver Diseases; Male; Middle Aged; Radioimmunoassay; Renin; Sodium; Syndrome | 1985 |
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Oligopeptides; Teprotide | 1985 |
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Creatinine; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1987 |
Prevention of renal damage and decrease of urinary kinins excretion by chronic treatments with enalapril and captopril in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Cerebrovascular Disorders; Enalapril; Hypertension, Renal; Kidney Diseases; Kinins; Male; Rats; Rats, Inbred SHR | 1987 |
Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis.
Topics: Captopril; Cyclosporins; Diagnosis, Differential; Humans; Kidney Diseases; Kidney Transplantation; Postoperative Complications; Renal Artery Obstruction; Renin | 1988 |
Selective IgA deficiency developed during treatment of scleroderma kidney with captopril.
Topics: Captopril; Dysgammaglobulinemia; Female; Humans; IgA Deficiency; Kidney Diseases; Middle Aged; Scleroderma, Systemic | 1988 |
[Progressive hyperkalemia during chronic captopril therapy (pharmacological hypoaldosteronism)].
Topics: Aged; Aldosterone; Captopril; Dose-Response Relationship, Drug; Humans; Hyperkalemia; Hypertension; Kidney; Kidney Diseases; Male | 1986 |
Cyclosporine nephrotoxicity: sodium excretion, autoregulation, and angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Cyclosporins; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Kidney; Kidney Diseases; Kidney Tubules; Male; Rats; Regional Blood Flow; Renin; Saralasin; Sodium; Time Factors | 1987 |
Use of captopril as early therapy for renal scleroderma: a prospective study.
Topics: Adult; Aged; Captopril; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Prospective Studies; Renin; Scleroderma, Systemic; Skin | 1985 |